AAAAAA

   
Results: 1-9 |
Results: 9
MODIFICATION OF PDGF-ALPHA RECEPTOR EXPRESSION OR FUNCTION ALTERS THEMETASTATIC PHENOTYPE OF 3LL CELLS
Authors: FITZERATTAS CJ DO MS FEIGELSON S VADAI E FELDMAN M EISENBACH L
Citation: Cj. Fitzerattas et al., MODIFICATION OF PDGF-ALPHA RECEPTOR EXPRESSION OR FUNCTION ALTERS THEMETASTATIC PHENOTYPE OF 3LL CELLS, Oncogene, 15(13), 1997, pp. 1545-1554
TUFTSIN-THF-GAMMA-2 CHIMERIC PEPTIDES - POTENTIAL NOVEL IMMUNOMODULATORS
Authors: GRANOTH R VADAI E BURSTEIN Y FRIDKIN M TZEHOVAL E
Citation: R. Granoth et al., TUFTSIN-THF-GAMMA-2 CHIMERIC PEPTIDES - POTENTIAL NOVEL IMMUNOMODULATORS, Immunopharmacology, 37(1), 1997, pp. 43-52
DAP KINASE LINKS THE CONTROL OF APOPTOSIS TO METASTASIS
Authors: INBAL B COHEN O POLAKCHARCON S KOPOLOVIC J VADAI E EISENBACH L KIMCHI A
Citation: B. Inbal et al., DAP KINASE LINKS THE CONTROL OF APOPTOSIS TO METASTASIS, Nature, 390(6656), 1997, pp. 180-184
IDENTIFICATION OF SHARED TUMOR-ASSOCIATED ANTIGEN PEPTIDES BETWEEN 2 SPONTANEOUS LUNG CARCINOMAS
Authors: MANDELBOIM O BARHAIM F VADAI E FRIDKIN M EISENBACH L
Citation: O. Mandelboim et al., IDENTIFICATION OF SHARED TUMOR-ASSOCIATED ANTIGEN PEPTIDES BETWEEN 2 SPONTANEOUS LUNG CARCINOMAS, The Journal of immunology, 159(12), 1997, pp. 6030-6036
REGRESSION OF ESTABLISHED MURINE CARCINOMA METASTASES FOLLOWING VACCINATION WITH TUMOR-ASSOCIATED ANTIGEN PEPTIDES
Authors: MANDELBOIM O VADAI E FRIDKIN M KATZHILLEL A FELDMAN M BERKE G EISENBACH L
Citation: O. Mandelboim et al., REGRESSION OF ESTABLISHED MURINE CARCINOMA METASTASES FOLLOWING VACCINATION WITH TUMOR-ASSOCIATED ANTIGEN PEPTIDES, Nature medicine, 1(11), 1995, pp. 1179-1183
EXPRESSION OF 2 H-2K GENES, SYNGENEIC AND ALLOGENEIC, AS A STRATEGY FOR POTENTIATING IMMUNE RECOGNITION OF TUMOR-CELLS
Authors: MANDELBOIM O VADAI E FELDMAN M EISENBACH L
Citation: O. Mandelboim et al., EXPRESSION OF 2 H-2K GENES, SYNGENEIC AND ALLOGENEIC, AS A STRATEGY FOR POTENTIATING IMMUNE RECOGNITION OF TUMOR-CELLS, Gene therapy, 2(10), 1995, pp. 757-765
COMBINED VACCINATION WITH MAJOR HISTOCOMPATIBILITY CLASS-I AND INTERLEUKIN-2 GENE-TRANSDUCED MELANOMA-CELLS SYNERGIZES THE CURE OF POSTSURGICAL ESTABLISHED LUNG METASTASES
Authors: PORGADOR A TZEHOVAL E VADAI E FELDMAN M EISENBACH L
Citation: A. Porgador et al., COMBINED VACCINATION WITH MAJOR HISTOCOMPATIBILITY CLASS-I AND INTERLEUKIN-2 GENE-TRANSDUCED MELANOMA-CELLS SYNERGIZES THE CURE OF POSTSURGICAL ESTABLISHED LUNG METASTASES, Cancer research, 55(21), 1995, pp. 4941-4949
EFFECTIVE ANTIMETASTATIC MELANOMA VACCINATION WITH TUMOR-CELLS TRANSFECTED WITH MHC GENES AND OR INFECTED WITH NEWCASTLE-DISEASE VIRUS (NDV)/
Authors: PLAKSIN D PORGADOR A VADAI E FELDMAN M SCHIRRMACHER V EISENBACH L
Citation: D. Plaksin et al., EFFECTIVE ANTIMETASTATIC MELANOMA VACCINATION WITH TUMOR-CELLS TRANSFECTED WITH MHC GENES AND OR INFECTED WITH NEWCASTLE-DISEASE VIRUS (NDV)/, International journal of cancer, 59(6), 1994, pp. 796-801
IMMUNOTHERAPY VIA GENE-THERAPY - COMPARISON OF THE EFFECTS OF TUMOR-CELLS TRANSDUCED WITH THE INTERLEUKIN-2, INTERLEUKIN-6, OR INTERFERON-GAMMA GENES
Authors: PORGADOR A TZEHOVAL E VADAI E FELDMAN M EISENBACH L
Citation: A. Porgador et al., IMMUNOTHERAPY VIA GENE-THERAPY - COMPARISON OF THE EFFECTS OF TUMOR-CELLS TRANSDUCED WITH THE INTERLEUKIN-2, INTERLEUKIN-6, OR INTERFERON-GAMMA GENES, Journal of immunotherapy with emphasis on tumor immunology, 14(3), 1993, pp. 191-201
Risultati: 1-9 |